BioStock has interviewed CEO Nils Brünner, Scandion Oncology, and CEO Ole Thastrup, 2cureX, about the Eurostars project on antiestrogen resistance.
The full interview is freely available here: https://www.biostock.se/2020/06/scandion-oncology-och-2curex-erhaller-bidrag-fran-eurostars/